000 | 01449 a2200409 4500 | ||
---|---|---|---|
005 | 20250515091218.0 | ||
264 | 0 | _c20071219 | |
008 | 200712s 0 0 eng d | ||
022 | _a0963-0643 | ||
024 | 7 |
_a10.1097/MOU.0b013e3282f0ebef _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSprenkle, Preston C | |
245 | 0 | 0 |
_aPathologic effects of testosterone deprivation. _h[electronic resource] |
260 |
_bCurrent opinion in urology _cNov 2007 |
||
300 |
_a424-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAffect _xdrug effects |
650 | 0 | 4 |
_aAndrogen Antagonists _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadverse effects |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 |
_aEndocrine System _xdrug effects |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 |
_aHot Flashes _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLibido _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Syndrome _xetiology |
650 | 0 | 4 |
_aMusculoskeletal System _xdrug effects |
650 | 0 | 4 |
_aOrchiectomy _xadverse effects |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSexual Behavior _xdrug effects |
700 | 1 | _aFisch, Harry | |
773 | 0 |
_tCurrent opinion in urology _gvol. 17 _gno. 6 _gp. 424-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/MOU.0b013e3282f0ebef _zAvailable from publisher's website |
999 |
_c17443052 _d17443052 |